Exclusive Interview: Global Head Biologics Safety Assessment at MedImmune Inc.

Exclusive Interview: Global Head Biologics Safety Assessment at MedImmune Inc.
Ahead of the Biosimilars Clinical Studies & Analytical Similarity Summit this March in Boston, we sat down with Dr. Rakesh Dixit, Vice President R&D, Global Head Biologics Safety Assessment at MedImmune Inc. to provide you with a sneak peek at what he will be discussing during his session at this years summit!

Please note: That all fields marked with an asterisk (*) are required.